CIMD Biomaterial Bank

storage box with biosamples is taken off from the cryogenic container
© Fraunhofer IZI

The collection and storage of biospecimens and associated data for research purposes forms an important component of medical research. In the biomaterial bank of the Fraunhofer Cluster of Excellence Immune-Mediated Diseases CIMD, human samples from the field of immune diseases are stored and used for scientific research.

The CIMD biomaterial bank combines the biobanks of the Fraunhofer IZI in Leipzig, the Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP) in Frankfurt and the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) in Hannover. Human biomaterial from the field of immune diseases, including blood, tissue, stool and urine, is collected and stored locally at the three sites. The administration is done via a central CIMD sample database.

Use of the sample and/or data is possible upon request and within the framework of a joint project or cooperation agreement. Please note that only human material, but no murine samples from the field of immune diseases are stored in the biobank.

We have access to the following biomaterials from patients via our institutes’ biobanks:


  • Ataxia teleangiectasia
  • Asthma (LPS challenge)
  • Asthma (rhinovirus challenge)
  • Chronic inflammatory bowel disease
  • COPD GOLD 1-4
  • Eosinophilic fasciitis
  • Lupus erythematosus
  • Granulomatosis with polyangiitis
  • Psoriatic arthritis
  • Psoriasis vulgaris
  • Rheumatoid arthritis
  • Rhinitis
  • Sarkoidosis
  • Spondyloarthritiden
  • Systemic sclerosis
  • Tumor


  • Bronchoalveolar lavage
  • Citrate plasma
  • DNA, RNA
  • EDTA whole blood
  • Skin biopsies
  • Heparin plasma
  • Lung biopsies
  • Nasopharyngeal lavage
  • PAXgene
  • PBMCs
  • Serum
  • Sputum
  • Stool, urine
  • Synovial fluid and synovia (tissue)
  • Cells from BAL (bronchoalveolar lavage), NAL (nasal lavage), and sputum
  • Cell culture supernatant